The objectives of the Midwest Children's Cancer Center (MCCC) are to reduce the incidence and mortality from childhood cancers through early diagnosis, evaluation, treatment, follow-up care and clinical and laboratory research. Accomplishments towards these goals include establishment of: a referral center for children with cancer in southeastern Wisconsin; a cancer education program for medical, paramedical and lay personnel; cooperative protocols (ALL, AML, neuroblastoma); Phase I-II drug trials a bone marrow transplantation program; an active home care program; psychological and social support groups; protocols designed to evaluate sequelae of cancer treatments; active laboratory research in tumor immunology and pharmacology. The purpose of the MCC's affiliation with POG is to enhance our probability of contributing to the nationwide effort to reduce the incidence and mortality of childhood cancer. MCCC will collaborate with other POG members in the areas of immunology, pharmacology, and assignment of our patients to POG protocols. We will participate in design of protocols for leukemias, solid tumors, and new agents. Laboratory investigations of reasons for protocol successes and failures will accompany clinical studies. Participation in a common milieu with others interested in childhood cancers should enhance efforts to combat these diseases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA032053-03
Application #
3557223
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1983-01-01
Project End
1986-01-31
Budget Start
1985-01-01
Budget End
1986-01-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Crews, Kristine R; Zhou, Yinmei; Pauley, Jennifer L et al. (2010) Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia. Cancer 116:227-32
Wacker, Pierre; Land, Vita J; Camitta, Bruce M et al. (2007) Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol 29:627-32
Whitehead, V M; Shuster, J J; Vuchich, M J et al. (2005) Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia 19:533-6
Ravindranath, Y; Chang, M; Steuber, C P et al. (2005) Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 19:2101-16
Ramakers-van Woerden, N L; Beverloo, H B; Veerman, A J P et al. (2004) In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia 18:521-9
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Goorin, Allen M; Schwartzentruber, Douglas J; Devidas, Meenakshi et al. (2003) Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21:1574-80
Blanco, Javier G; Edick, Mathew J; Hancock, Michael L et al. (2002) Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 12:605-11
Lacayo, N J; Lum, B L; Becton, D L et al. (2002) Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. Leukemia 16:920-7
Laver, Joseph H; Mahmoud, Hazem; Pick, Terry E et al. (2002) Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study. Leuk Lymphoma 43:105-9

Showing the most recent 10 out of 34 publications